Ledger.Open graph →
SEC Form D · filed September 2, 2021

Aarvik Therapeutics, Inc

Offering
$8.3M
Sold
$8.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
FREMONT, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Jagath Reddy Junutula · Fremont, CAExec · DirectorAnula Jayasuriya · Fremont, CADirectorRichard Scheller · San Francisco, CADirectorRichard Scheller · San Francisco, CADirectorJagath Reddy Junutula · Fremont, CAExec · DirectorAnula Jayasuriya · Los Altos, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗